3-11-2021As the 2021 virtual Conference on Retroviruses and Opportunistic Infections (CROI) concluded, NIH’s Dr. Carl Dieffenbach joined HIV.gov for a conversation abo…
3-9-2021In an HIV.gov video conversation yesterday, NIH’s Dr. Carl Dieffenbach shared highlights from HIV research presented at the 2021 virtual Conference on Retrovi…
3-9-2021Cross-posted from NCHHSTP NewsroomCDC scientists will present nearly 30 abstracts at the 2021 Conference on Retroviruses and Opportunistic Infections (CROI). …
3-4-2021Next week, HIV.gov will be sharing updates on the latest HIV research from the 2021 virtual Conference on Retroviruses and Opportunistic Infections (CROI). Watc…
4-23-2020As a participant in the recent virtual 2020 Conference on Retroviruses and Opportunistic Infections (CROI), I found several studies to be particularly relevant …
3-31-2020The 2020 Conference on Retroviruses and Opportunistic Infections (CROI) was convened as a virtual conference earlier this month. Each year, thousands of researc…
3-11-2020Cross-posted from NIAID NewsroomDolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women.The antiretrov…
3-9-2020Cross-posted from NIAID NewsroomAmong African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug tenof…
3-9-2020Cross-posted from NIAID NewsroomA new approach to direct the body to make a specific antibody against HIV led to sustained production of that antibody for more …
